Human liver cancer organoids: Biological applications, current challenges, and prospects in hepatoma therapy

L Chen, X Wei, D Gu, Y Xu, H Zhou - Cancer Letters, 2023 - Elsevier
Liver cancer and disease are among the most socially challenging global health concerns.
Although organ transplantation, surgical resection and anticancer drugs are the main …

CRISPR engineering in organoids for gene repair and disease modelling

MH Geurts, H Clevers - Nature Reviews Bioengineering, 2023 - nature.com
Organoids bridge the gap between 2D cell lines and in vivo studies. With their 3D
organization and cellular heterogeneity, adult stem cell-derived organoids closely resemble …

Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance

DF Calvisi, L Boulter, J Vaquero… - Nature Reviews …, 2023 - nature.com
Cholangiocarcinoma (CCA) is a rare malignancy that develops at any point along the biliary
tree. CCA has a poor prognosis, its clinical management remains challenging, and effective …

Organoid cultures for cancer modeling

HHN Yan, AS Chan, FPL Lai, SY Leung - Cell Stem Cell, 2023 - cell.com
Organoids derived from adult stem cells (ASCs) and pluripotent stem cells (PSCs) are
important preclinical models for studying cancer and developing therapies. Here, we review …

Quantification of absolute transcription factor binding affinities in the native chromatin context using BANC-seq

HK Neikes, KW Kliza, C Gräwe, RA Wester… - Nature …, 2023 - nature.com
Transcription factor binding across the genome is regulated by DNA sequence and
chromatin features. However, it is not yet possible to quantify the impact of chromatin context …

Extracellular matrix drives tumor organoids toward desmoplastic matrix deposition and mesenchymal transition

GS van Tienderen, O Rosmark, R Lieshout, J Willemse… - Acta biomaterialia, 2023 - Elsevier
Patient-derived tumor organoids have been established as promising tools for in vitro
modelling of multiple tumors, including cholangiocarcinoma (CCA). However, organoids are …

CRISPR/Cas9: A powerful genome editing technique for the treatment of cancer cells with present challenges and future directions

A Hazafa, M Mumtaz, MF Farooq, S Bilal, SN Chaudhry… - Life sciences, 2020 - Elsevier
Cancer is one of the most leading causes of death and a major public health problem,
universally. According to accumulated data, annually, approximately 8.5 million people died …

Organoid: Bridging the gap between basic research and clinical practice

G Weng, J Tao, Y Liu, J Qiu, D Su, R Wang, W Luo… - Cancer Letters, 2023 - Elsevier
Nowadays, the diagnosis and treatment system of malignant tumors has increasingly tended
to be more precise and personalized. And the existing tumor models are still unable to fully …

[HTML][HTML] On-chip modeling of tumor evolution: Advances, challenges and opportunities

C Li, JB Holman, Z Shi, B Qiu, W Ding - Materials Today Bio, 2023 - Elsevier
Tumor evolution is the accumulation of various tumor cell behaviors from tumorigenesis to
tumor metastasis and is regulated by the tumor microenvironment (TME). However, the …

TP53 R249S mutation in hepatic organoids captures the predisposing cancer risk

YK Lam, J Yu, H Huang, X Ding, AM Wong… - Hepatology, 2023 - journals.lww.com
TP53 R249S mutation in hepatic organoids captures the predis... : Hepatology TP53 R249S
mutation in hepatic organoids captures the predisposing cancer risk : Hepatology AASLD …